Marcin Hoffmann
Private Equity Investor chez BIB Seed Capital Management
Profil
Marcin Hoffmann is currently the Investment Manager & CEO at BIB Seed Capital Management since 2007.
He previously worked as a Project Manager at Instytut Bioinfobank Sp zoo from 2004 to 2011 and as a Member-Supervisory Board at Medicalgorithmics SA, Genovum Sp zoo, and Proteon Pharmaceuticals SA. Dr. Hoffmann holds an MBA from Georgia State University, a doctorate degree from Adam Mickiewicz University, and a graduate degree from the same university.
Postes actifs de Marcin Hoffmann
| Sociétés | Poste | Début |
|---|---|---|
BIB Seed Capital Management
 BIB Seed Capital Management Investment ManagersFinance BIB Seed Capital Management (BIB Seed Capital) is the venture capital subsidiary of Instytut Bioinfobank Sp zoo. The firm was founded in 2007, and is headquartered in Poznan, Poland. | Private Equity Investor | 01/02/2007 |
Anciens postes connus de Marcin Hoffmann
| Sociétés | Poste | Fin |
|---|---|---|
Genovum Sp zoo
 Genovum Sp zoo BiotechnologyHealth Technology Genovum Sp zoo provides biological data processing services. It offers services to the frontier industries: information technology, biotechnology, and health care. Its business involves the use of bioinformatics methods to support the sequencing of genomes, development of new enzymes, and new simple organisms with medicinal properties. Genovum was founded in August 2008 and is headquartered in Warschaw, Poland | Directeur/Membre du Conseil | 01/01/2012 |
| Instytut Bioinfobank Sp zoo | Corporate Officer/Principal | 01/01/2011 |
Proteon Pharmaceuticals SA
 Proteon Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Proteon Pharmaceuticals SA develops, manufactures, and sells pharmaceutical products and drugs. The firm offers Bafasal and Bafador. Its services include Veterinary autovaccines and In vitro tests for drug research. The company was founded in 2005 and is headquartered in Lodz, Poland. | Directeur/Membre du Conseil | - |
| MEDICALGORITHMICS S.A. | Directeur/Membre du Conseil | - |
Formation de Marcin Hoffmann
| Georgia State University | Masters Business Admin |
| Adam Mickiewicz University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEDICALGORITHMICS S.A. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Instytut Bioinfobank Sp zoo | |
BIB Seed Capital Management
BIB Seed Capital Management Investment ManagersFinance BIB Seed Capital Management (BIB Seed Capital) is the venture capital subsidiary of Instytut Bioinfobank Sp zoo. The firm was founded in 2007, and is headquartered in Poznan, Poland. | Finance |
Genovum Sp zoo
Genovum Sp zoo BiotechnologyHealth Technology Genovum Sp zoo provides biological data processing services. It offers services to the frontier industries: information technology, biotechnology, and health care. Its business involves the use of bioinformatics methods to support the sequencing of genomes, development of new enzymes, and new simple organisms with medicinal properties. Genovum was founded in August 2008 and is headquartered in Warschaw, Poland | Health Technology |
Proteon Pharmaceuticals SA
Proteon Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Proteon Pharmaceuticals SA develops, manufactures, and sells pharmaceutical products and drugs. The firm offers Bafasal and Bafador. Its services include Veterinary autovaccines and In vitro tests for drug research. The company was founded in 2005 and is headquartered in Lodz, Poland. | Health Technology |